体部伽玛刀治疗i、ii期非小细胞肺癌的近期疗效观察空军总医院放疗科.pptVIP

下载本文档

0
0
约2.84千字
约 12页
2018-05-28 发布于浙江
举报
版权申诉

体部伽玛刀治疗i、ii期非小细胞肺癌的近期疗效观察空军总医院放疗科.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

体部伽玛刀治疗i、ii期非小细胞肺癌的近期疗效观察空军总医院放疗科

Promising clinical outcome of stereotactic body radiosurgery in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer? Tingyi Xia,1 Qingxuan Sun,1 Hongqi Li, 1Yingjie Wang, 1 and Joe Y. Chang2 1 Department of Radiation Oncology, Air Force General Hospital, Beijing, China; 2 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA Material and Methods: 43 patients of stage I (n=25) and II (n=18) NSCLC KPS 70 Local control was evaluated based on the CT images at 3, 6, 12 months after treatment and then as clinically indicated Kaplan-Meier was used to calculate survival rate and local control rate. Treatment design: CT-Sim PTV: GTV + 1 cm Single focus or multi-focus radiation was used according to different sizes of target Dose prescribed to 50% dose line 50% dose line covers PTV and 75% dose line covers more than 95% of GTV. Radiation dose: 50 GY with 5 GY/ fraction For N1 case of lymph node in lung hilum, same or slightly less dose was delivered to LN 30 cobalt-60 sources scattered in the cavity of the primary collimator. The source body rotates horizontally around the central axis and 30 bundles of gamma radials were focalized onto focus point. Three sizes of collimators with dose focus of 1 cm, 3 cm and 5 cm. Smaller focus achieves sharper dose gradient. Combination of three collimators, 1-10cm tumors can be treated. Results (1) Relation between clinical response and size of tumor Tumor n CR PR SD ＜3cm 25 68.0%（17/25) 32.0%(8/25) 　0 ＞3cm 18 55.6% （10/18) 33.3%(6/18) 11.1%（2/18) P 0.05 (2) Relation between stage and LC and OS 　　　　　　　　LC（%）　　　　 OS（%）　　　　　　　 1Y　 2Y　3Y　　　 1Y　2Y　3Y I　 25　　　 100 96.0 96.0 100　90.9 90.9 II　 18　　　 88.9 83.3 83